Novartis CEO: COVID-19 vaccine might take until end of 2021 to reach patients

Novartis CEO Vas Narasimhan forecast Thursday that a potential COVID-19 vaccine could take until the end of 2021 to reach an approval, throwing some cold water on drugmakers with aggressive timelines for their candidates, Bloomberg reported.